logo
#

Latest news with #GestationalDiabetesMellitus

MDRF and Russia's Almazov Centre Partner for diabetes research
MDRF and Russia's Almazov Centre Partner for diabetes research

Time of India

time26-05-2025

  • Health
  • Time of India

MDRF and Russia's Almazov Centre Partner for diabetes research

Chennai: The Madras Diabetes Research Foundation ( MDRF ) has signed a research collaboration with the Almazov National Medical Research Centre , based in Saint Petersburg, Russia. The partnership will focus on developing new diagnostics and treatment strategies for diabetes, with an emphasis on Gestational Diabetes Mellitus (GDM). It will also explore emerging areas such as artificial intelligence and precision medicine in diabetes care. The memorandum of understanding (MoU) was signed by Dr. V. Mohan of MDRF and Prof. Evgeny Shlyakhto, Director General of the Almazov Centre. The agreement includes training and exchange programs for medical specialists, joint conferences, academic meetings, collaborative publications, and educational and cultural exchanges. Joint research projects on gestational diabetes have begun, involving Dr. Polina V. Popova and her team from Almazov's Endocrinology Department and Dr. Mohan's team at MDRF. The collaboration is expected to expand further in the coming months.

Gestational diabetes: A silent threat to pregnant women; doctor shares prevention tips to follow
Gestational diabetes: A silent threat to pregnant women; doctor shares prevention tips to follow

Hindustan Times

time28-04-2025

  • Health
  • Hindustan Times

Gestational diabetes: A silent threat to pregnant women; doctor shares prevention tips to follow

Gestational Diabetes Mellitus (GDM) is a form of glucose intolerance that develops during pregnancy. While commonly considered a temporary complication that resolves after childbirth, GDM carries significant health risks for both the mother and the unborn child. Also read | What is Type 5 diabetes, the condition that affects 25 million people worldwide? In an interview with HT Lifestyle, Dr. Shubhashree Patil, diabetologist and physician, Diabetes & Wellness Clinic, Mumbai said, 'Often undiagnosed or underestimated, GDM acts as a silent threat, exacerbating conditions such as hypertension, infections, and cardiovascular issues, which may ultimately lead to fatal outcomes. Understanding this link is crucial in promoting awareness, improving maternal care protocols, and ensuring safer pregnancies.' The doctor noted down advanced maternal age, obesity or excessive weight gain during pregnancy, family history of diabetes, previous history of GDM or macrosomia and polycystic ovarian syndrome as the risk factors that can trigger gestational diabetes. 'GDM results from insulin resistance due to placental hormones, compounded by maternal metabolic stress. If uncontrolled, it leads to hyperglycemia, promoting endothelial dysfunction, hypertension, and increased inflammatory markers,' the doctor added. Also read | Your diabetes could be damaging your kidneys. Here's how to stop it 'Though GDM is often silent and short-lived, its consequences can be fatal. Early diagnosis, targeted interventions, and postnatal care are essential to curb the maternal mortality associated with this preventable condition,' Dr. Shubhashree Patil highlighted. Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store